Evidence map›Paper›PMID 40500722›Full record

ArticleOrphanet journal of rare diseases2025

Patients with suspected pulmonary hypertension based on echocardiography in Behçet's disease: a 5-year follow-up study.

Mustafa Ekici, Alper Sarı, Berkan Armağan, Erdinç Ünaldı, Büşra Fırlatan, Gözde Sevgi Kart Bayram, Buğu Bulat, Uğur Nadir Karakulak, Levent Kılıç, Barış Kaya and 2 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mustafa EkiciDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey. ekici42mustafa@gmail.com.ORCID http://orcid.org/0000-0002-8757-6226
Alper SarıDepartment of Rheumatology, Etlik City Hospital, Yenimahalle, Ankara, Turkey.
Berkan ArmağanDepartment of Rheumatology, Bilkent City Hospital, Çankaya, Ankara, Turkey.
Erdinç ÜnaldıDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Büşra FırlatanDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Gözde Sevgi Kart BayramDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Buğu BulatDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Uğur Nadir KarakulakDepartment of Cardiology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Levent KılıçDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Barış KayaDepartment of Cardiology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Ömer KaradağDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.
Ali AkdoğanDepartment of Rheumatology, Faculty of Medicine, Hacettepe University, Altındağ, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study investigates the long-term functional and transthoracic echocardiographic (TTE) progression in Behcet's disease (BD) patients with pulmonary hypertension (PH), aiming to address knowledge gaps regarding PH in BD.

methodsThis study included 17 BD patients with PH detected by TTE and 6 patients with pulmonary artery involvement but without PH from a previous study at Hacettepe University. PH was defined as an estimated systolic pulmonary artery pressure (sPAP) ≥ 40 mmHg. TTE was conducted by a cardiologist blinded to clinical information, with sPAP calculated using the simplified Bernoulli equation. Right heart catheterization was performed only in two patients who underwent pulmonary endarterectomy operations.

resultsAll 23 patients were reached by telephone, and 13 of the 17 with PH attended the clinic for reevaluation and a TTE was performed. After 5 years, all patients were alive. Clinical worsening or FC progression was not observed in any patient with PH except the ones with Group IV PH. Pulmonary endarterectomy (PEA) was performed in 2 of the 4 Group IV PH patients during follow-up. Additional Group II PH diagnosed due to mitral valve disease in a patient with Group IV PH. Other than the ones who underwent PEA there were no increase in sPAP of the BD patients with PH. Among patients with PAI but without PH during first evaluation; only one was mildly symptomatic after 5 years who had a normal sPAP.

conclusionProgressive PH was observed only in Group IV PH patients, while other groups remained generally asymptomatic. Although the number of patients enrolled in this study is limited implementation of TEE to the follow-up of BD patients with PAI for screening and monitoring PH can be beneficial for early diagnosis and defining treatment strategy.

Indexed as

Behcet SyndromeEchocardiographyHypertension, PulmonaryAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedPulmonary ArteryBehçet's diseasePulmonary endarterectomyPulmonary hypertensionTransthoracic echocardiography

Identifiers

PMID40500722
PMCPMC12160349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.